Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Trulieve Cannabis (TCNNF) EBIT (2020 - 2025)

Trulieve Cannabis (TCNNF) has 6 years of EBIT data on record, last reported at $15.3 million in Q4 2025.

  • For Q4 2025, EBIT rose 1069.5% year-over-year to $15.3 million; the TTM value through Dec 2025 reached $143.5 million, up 46.75%, while the annual FY2025 figure was $143.5 million, 46.75% up from the prior year.
  • EBIT reached $15.3 million in Q4 2025 per TCNNF's latest filing, down from $42.2 million in the prior quarter.
  • Across five years, EBIT topped out at $76.3 million in Q2 2021 and bottomed at -$291.3 million in Q2 2023.
  • Average EBIT over 5 years is $13.7 million, with a median of $29.2 million recorded in 2022.
  • Peak YoY movement for EBIT: crashed 802.35% in 2023, then surged 6734.63% in 2025.
  • A 5-year view of EBIT shows it stood at -$11.1 million in 2021, then soared by 146.96% to $5.2 million in 2022, then soared by 460.51% to $29.2 million in 2023, then plummeted by 95.52% to $1.3 million in 2024, then soared by 1069.5% to $15.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were $15.3 million in Q4 2025, $42.2 million in Q3 2025, and $52.6 million in Q2 2025.